Planta Med 2012; 78(15): 1636-1638
DOI: 10.1055/s-0032-1315208
Biological and Pharmacological Activity
Letters
Georg Thieme Verlag KG Stuttgart · New York

Inhibition of Herpes Simplex Virus Type 1 by Thymol-Related Monoterpenoids

Authors

  • Wen-Lin Lai

    1   School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung, Taiwan
    2   Clinical Laboratory, Chung Shan Medical University Hospital, Taichung, Taiwan
  • He-Shing Chuang

    3   Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan
  • Meng-Hwan Lee

    4   Division of Biotechnology, Animal Technology Institute Taiwan, Miaoli, Taiwan
    5   Yangsen Biotechnology Co., Ltd., Taipei, Taiwan
  • Chia-Li Wei

    5   Yangsen Biotechnology Co., Ltd., Taipei, Taiwan
    6   Department of Biochemical Science & Technology, National Chiayi University, Chiayi, Taiwan
  • Chin-Fu Lin

    7   Department of Clinical Microbiology Laboratory, Taichung Veterans General Hospital, Taichung, Taiwan
  • Ying-Chieh Tsai

    3   Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan
Further Information

Publication History

received 10 February 2012
revised 17 July 2012

accepted 18 July 2012

Publication Date:
13 August 2012 (online)

Abstract

This study examined the anti-herpes simplex virus type I activity of the major constituents of several essential oils. Plaque reduction assays were performed to evaluate anti-herpes simplex virus type I activity. Thymol and carvacrol both possessed significant antiviral activity with an IC50 of 7 µM, and herpes simplex virus type I was 90 % inactivated within 1 hr. The mode of antiviral action was shown to affect the virion directly. Evidence was also observed by electron microscopy. Evaluation of the structural requirements for antiviral activity of thymol-related monoterpenoids revealed that aliphatic side chains had a minor effect, while a hydrophilic group on the benzene ring was sufficient for activity. Our results suggest that thymol and carvacrol are potential candidates for topical therapeutic application to reduce herpes simplex virus transmission.